Target intelligence / Profile preview

Cell-surface carbohydrate

Molecular classification
Other, Glycan, Glycoprotein (component), Glycolipid (component), Proteoglycan (component)
01

Overview

Cell-surface carbohydrates are complex sugar moieties covalently linked to proteins (glycoproteins), lipids (glycolipids), or forming proteoglycans, and are prominently exposed on the extracellular surface of all cells[1][3][6]. These structures are key mediators of cell-cell recognition, signaling, adhesion, migration, and immune interactions, acting as "molecular identity badges" for individual cells[3][4][5][8]. They are major determinants of blood group antigens, mediate leukocyte rolling via selectin-ligand interactions, and serve as receptors or attachment sites for many pathogens[1][5]. Aberrant cell-surface carbohydrate profiles are characteristic features of malignant transformation and are frequently exploited as diagnostic biomarkers (e.g., CA19-9 in cancer)[5]. Due to their structural diversity and biosynthetic complexity, "cell-surface carbohydrates" is a collective, not individual molecular target: it refers to a broad class of biologically important moieties rather than a single protein, receptor, or canonical drug target[1][5][6][8].

Other names
Cell surface carbohydrateCell membrane carbohydrateGlycocalyx carbohydrates
02

Mechanism of action

Inhibit pathogen binding to host cells; Block cell adhesion molecules (e.g., selectin inhibitors); Mask or modify antigenic glycans (e.g., via glycosyltransferase inhibitors).

03

Biological functions

Cell recognitionCell adhesionImmune responseCell signalingProtection (e.g., resistance to mechanical stress)Determination of blood group antigensFacilitation of infection (bacterial/viral attachment)Sperm-egg recognition
04

Disease associations

Cancer (altered glycosylation in tumor cells)Infection (pathogen binding)Inflammation (regulation of leukocyte trafficking)Autoimmune disease (as antigens or involvement in immune evasion)Other
05

Safety considerations

Off-target effects due to widespread distribution of cell-surface glycansImmune reactions (e.g., anti-carbohydrate antibodies)Disruption of normal cell-cell recognitionAltered immune surveillance
06

Biomarkers

Blood group antigens (ABO, Lewis, etc.)Tumor-associated carbohydrate antigens (e.g., CA19-9, sialyl Lewis X)Glycocalyx integrity markers

Beyond the preview

Go deeper on Cell-surface carbohydrate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cell-surface carbohydrate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call